Verantos
Founded Year
2015Stage
Grant - II | AliveMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+70 points in the past 30 days
About Verantos
Verantos is a company that focuses on generating high-validity real-world evidence in the life sciences sector. The company offers a platform that integrates various real-world data sources and uses artificial intelligence to generate evidence with high accuracy, completeness, and traceability. This evidence is used to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.
Loading...
Verantos's Product Videos
Verantos's Products & Differentiators
Pragmatic Registry
Pragmatic Registry enables life sciences companies to subscribe to indication-specific data sets that represent patient cohorts generated using deep phenotyping and linkage. The research-grade RWE that powers the registry is developed using AI-driven insights. Real-world data informing the registry are sourced from both advanced data sources like clinical narratives in EHRs, as well as linked administrative data such as claims.
Loading...
Research containing Verantos
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Verantos in 3 CB Insights research briefs, most recently on Oct 10, 2022.
Expert Collections containing Verantos
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Verantos is included in 3 Expert Collections, including Digital Health.
Digital Health
11,109 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Artificial Intelligence
6,887 items
Verantos Patents
Verantos has filed 6 patents.
The 3 most popular patent topics include:
- computational linguistics
- health informatics
- medical terminology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/27/2023 | 5/21/2024 | Computational linguistics, Natural language processing, Medical terminology, Tasks of natural language processing, Semantics | Grant |
Application Date | 6/27/2023 |
|---|---|
Grant Date | 5/21/2024 |
Title | |
Related Topics | Computational linguistics, Natural language processing, Medical terminology, Tasks of natural language processing, Semantics |
Status | Grant |
Latest Verantos News
Aug 16, 2024
News provided by Share this article Share toX Global leader in high-validity real-world evidence for life sciences grows more than 3x in three years PALO ALTO, Calif., Aug. 16, 2024 /PRNewswire/ -- Verantos , the global leader in high-validity real-world evidence (RWE) for the life sciences, marks its third consecutive appearance on the Inc. 5000, ranking No. 1393 on the annual list of the fastest-growing private companies in America. The prestigious Inc. 5000 provides a data-driven look at the most successful independent and entrepreneurial businesses in the U.S. Past honorees including Microsoft, Meta, Chobani, and Under Armour. Verantos is the only RWE company to earn a spot on the Inc. 5000 list this year. Verantos' appearance on the Inc. 5000 underscores the rapid adoption of high-validity real-world evidence and Verantos' commitment to providing life sciences organizations with rich and reliable real-world data (RWD) through advanced curation, linkage, and enrichment. "Our sustained growth reflects the value we deliver to our clients, including by providing them with the rich and reliable real-world data they need to advance groundbreaking treatments," said Dan Riskin, Verantos CEO. "We are honored to be recognized alongside many other dynamic and entrepreneurial companies for the third consecutive year." Inc. reports the Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. About Verantos Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to the complete patient record, Verantos enables life sciences organizations to generate high-validity evidence across therapeutic areas with measured accuracy, completeness, and traceability. Credible evidence accelerates clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives. For more information, visit Verantos.com or follow us on LinkedIn . Media Contact
Verantos Frequently Asked Questions (FAQ)
When was Verantos founded?
Verantos was founded in 2015.
Where is Verantos's headquarters?
Verantos's headquarters is located at 325 Sharon Park Dr., Menlo Park.
What is Verantos's latest funding round?
Verantos's latest funding round is Grant - II.
Who are the investors of Verantos?
Investors of Verantos include National Science Foundation, National Institutes of Health and National Center For Advancing Translational Sciences.
Who are Verantos's competitors?
Competitors of Verantos include Mendel AI, TriNetX, CorEvitas, Savana, Nyquist Data and 7 more.
What products does Verantos offer?
Verantos's products include Pragmatic Registry and 1 more.
Who are Verantos's customers?
Customers of Verantos include Amgen and FDA.
Loading...
Compare Verantos to Competitors
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
MediMergent is a data collection and analytics company operating in the healthcare sector. The company's main services include the collection and analysis of real-world evidence, with a focus on capturing and utilizing the voice of the patient. MediMergent primarily serves pharmaceutical and life science companies, health insurers and payers, and data analytics aggregators. It was founded in 2014 and is based in Rockville, Maryland.
Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Promptly Health is a global provider of end-to-end Real World Evidence solutions in the healthcare sector. The company's main services include the generation of new knowledge from harmonized clinical, socio-economic, and claims data, augmented with the collection of longitudinal patient-reported data and patient-generated digital biomarkers. Promptly Health primarily sells to the life sciences sector, healthcare providers, and healthcare payers. It was founded in 2017 and is based in Porto, Portugal.
ConcertAI is a leader in clinical artificial intelligence and real-world data products within the healthcare sector. The company offers a suite of AI-driven solutions and services designed to optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions. ConcertAI primarily serves the oncology research and clinical development sectors. It was founded in 2017 and is based in Cambridge, Massachusetts.
Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.
Loading...